Exploring the Link Between Cephalosporin Antibiotic Use and Urolithiasis: A Case–Control Study

Main Article Content

R. Gandhimathi

Abstract

Purpose: The study aimed to explore the association between cephalosporin antibiotics and urolithiasis, specifically
focusing on Oxalobacter formigenes ( O. formigenes) a colonization process. Materials and Methods: An
observation was made that 50 were among patients, with kidney stones and 110 without stones had participated
in the study. O. formigenes, a bacterium known to metabolize oxalates in the gastrointestinal tract, was detected
in 36 of the 50 kidney stone patients and in 97 of the 110 control participants. Results: It was found that calcium
and oxalate levels in urine. There was a significant increase in kidney stone patients than in controls, suggesting
that these elevated levels may contribute to stone formation. Given the sensitivity of O. formigenes to certain
antibiotics, including cephalosporins, frequent antibiotic use may reduce O. formigenes. This reduction could lead
to increased oxalate absorption, as O. formigenes is not present to metabolize oxalates effectively. Conclusion:
Thereby heightening Formation of kidney stones is at risk. According to these findings, the absence or reduction of
species colonization may contribute to calcium oxalate stone pathogenesis, especially in patients taking antibiotics
such as cephalosporins. Consequently, this study highlights the need for cautious antibiotic use to preserve
beneficial gut microbiota, which assists protecting against diagnosis and treatment of kidney stones. Further
research could confirm these associations and guide antibiotic stewardship practices to prevent disruptions in gut
microbiome balance that might contribute to urolithiasis.

Downloads

Download data is not yet available.

Article Details

How to Cite
R. Gandhimathi. (2024). Exploring the Link Between Cephalosporin Antibiotic Use and Urolithiasis: A Case–Control Study. Asian Journal of Pharmaceutics (AJP), 18(04). https://doi.org/10.22377/ajp.v18i04.5860
Section
ORIGINAL ARTICLES